GB0130695D0 - Pyrazola[4,3]pyrimidine - Google Patents

Pyrazola[4,3]pyrimidine

Info

Publication number
GB0130695D0
GB0130695D0 GB0130695A GB0130695A GB0130695D0 GB 0130695 D0 GB0130695 D0 GB 0130695D0 GB 0130695 A GB0130695 A GB 0130695A GB 0130695 A GB0130695 A GB 0130695A GB 0130695 D0 GB0130695 D0 GB 0130695D0
Authority
GB
United Kingdom
Prior art keywords
pyrazola
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0130695A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0130695A priority Critical patent/GB0130695D0/en
Publication of GB0130695D0 publication Critical patent/GB0130695D0/en
Priority to HN2002000317A priority patent/HN2002000317A/en
Priority to DO2002000482A priority patent/DOP2002000482A/en
Priority to JP2003540180A priority patent/JP2005511575A/en
Priority to EP02777623A priority patent/EP1440073A1/en
Priority to BR0214096-9A priority patent/BR0214096A/en
Priority to PCT/IB2002/004385 priority patent/WO2003037899A1/en
Priority to MXPA04004171A priority patent/MXPA04004171A/en
Priority to CA002466824A priority patent/CA2466824A1/en
Priority to PA20028557401A priority patent/PA8557401A1/en
Priority to UY27522A priority patent/UY27522A1/en
Priority to PE2002001070A priority patent/PE20030702A1/en
Priority to US10/283,514 priority patent/US20030195205A1/en
Priority to ARP020104152A priority patent/AR037329A1/en
Priority to TW091132424A priority patent/TW200300081A/en
Priority to SV2002001373A priority patent/SV2004001373A/en
Ceased legal-status Critical Current

Links

GB0130695A 2001-11-02 2001-12-21 Pyrazola[4,3]pyrimidine Ceased GB0130695D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0130695A GB0130695D0 (en) 2001-12-21 2001-12-21 Pyrazola[4,3]pyrimidine
HN2002000317A HN2002000317A (en) 2001-11-02 2002-10-01 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
DO2002000482A DOP2002000482A (en) 2001-11-02 2002-10-09 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
CA002466824A CA2466824A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
PCT/IB2002/004385 WO2003037899A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
EP02777623A EP1440073A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
BR0214096-9A BR0214096A (en) 2001-11-02 2002-10-22 Pde9 inhibitors for the treatment of cardiovascular disorders
JP2003540180A JP2005511575A (en) 2001-11-02 2002-10-22 PDE9 inhibitors for treating cardiovascular disorders
MXPA04004171A MXPA04004171A (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders.
PA20028557401A PA8557401A1 (en) 2001-11-02 2002-10-29 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
US10/283,514 US20030195205A1 (en) 2001-11-02 2002-10-30 PDE9 inhibitors for treating cardiovascular disorders
UY27522A UY27522A1 (en) 2001-11-02 2002-10-30 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
PE2002001070A PE20030702A1 (en) 2001-11-02 2002-10-30 PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
ARP020104152A AR037329A1 (en) 2001-11-02 2002-10-31 PIRAZOLO PIRIMIDINONA COMPOUNDS, PROCEDURES FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL COMPOSITIONS OF THE SAME AND USES OF THE SAME IN THE PREPARATION OF MEDICINES
TW091132424A TW200300081A (en) 2001-11-02 2002-11-01 Pde9 inhibitors for treating cardiovascular disorders
SV2002001373A SV2004001373A (en) 2001-11-02 2002-11-01 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS. REF. PCS22051

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0130695A GB0130695D0 (en) 2001-12-21 2001-12-21 Pyrazola[4,3]pyrimidine

Publications (1)

Publication Number Publication Date
GB0130695D0 true GB0130695D0 (en) 2002-02-06

Family

ID=9928202

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0130695A Ceased GB0130695D0 (en) 2001-11-02 2001-12-21 Pyrazola[4,3]pyrimidine

Country Status (1)

Country Link
GB (1) GB0130695D0 (en)

Similar Documents

Publication Publication Date Title
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
IL158697A0 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
IL163817A0 (en) 2,4-Diaminopyrimidine
HK1070071A1 (en) New pyrimidine compounds
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
IL162189A0 (en) Pyrimidine compounds
PL358551A1 (en) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
MXPA03004453A (en) Pyrimidine derivatives.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
GB0112802D0 (en) Pyrimidine derivatives
GB0104554D0 (en) New uses
GB0112803D0 (en) Pyrimidine derivatives
MXPA03000504A (en) Pyrimidine derivatives.
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
GB0130695D0 (en) Pyrazola[4,3]pyrimidine
GB0119477D0 (en) Pyrimidine derivatives
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
PL371851A1 (en) 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
AU2002258620A1 (en) (oxo-pyrazolo(1,5a)pyrimidin-2-yl)alkyl-carboxamides
TJ20020735A (en) 2-bROM-7-METHIL-5-OXO-5H-1,3,4-thyodyazol Ä3,2-AÜ pyrimidin
GB0112804D0 (en) Pyrimidine derivatives
GB0112807D0 (en) Pyrimidine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)